This session will cover the current protocols and best practices for conducting ADA assays during clinical immunogenicity assessments. Moreover, the speakers will delve into immunogenicity risk assessment, providing insights into evaluating potential immune responses and their impact on drug efficacy and safety.
Register for this webinar today to gain critical insights into the evolving landscape of ADA and immunogenicity testing in bioanalytical settings.
Join experts from KCAS Bio, Cheikh Kane, PhD, Executive Director, Biopharma Services; and Dominic Warrino, PhD, Senior Director of Scientific Services, for the live webinar on Thursday, August 29, 2024, at 1pm EDT (10am PDT).
For more information, or to register for this event, visit Navigating the Current Landscape of Anti-Drug Antibodies Testing from Preclinical to the Clinical Stages.
ABOUT XTALKS
Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars and digital content to the global life science, food, healthcare and medical device communities. Every year, thousands of industry practitioners (from pharmaceutical, biotechnology, food, healthcare and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps professionals stay current with industry developments, regulations and jobs. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.
To learn more about Xtalks visit https://xtalks.com
For information about hosting a webinar visit https://xtalks.com/why-host-a-webinar/
Media Contact
Vera Kovacevic, Xtalks, +1 (416) 977-6555 x371, [email protected], https://xtalks.com
SOURCE Xtalks
